2371 Validation of a novel PD-L1 assay for bladder cancer circulating tumor cells

OBJECTIVES/SPECIFIC AIMS: Bladder cancer patients being considered for immune checkpoint blockade are often judged on immunohistochemical staining for the checkpoint target protein PD-L1 in the original surgery or biopsy sample. However, sampling error or the clinical evolution of most patients’ can...

Descripción completa

Detalles Bibliográficos
Autores principales: Seranio, Nicolas, Aguarin, Louise, Dorsey, Jay F., Christodouleas, John P., Kao, Gary D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Basic/Translational Science/Team Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798935/
http://dx.doi.org/10.1017/cts.2018.150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798935/
http://dx.doi.org/10.1017/cts.2018.150

Ejemplares similares